Corresponding to the effects of cholesterol on tumor growth, PCSK9 inhibition also has cholesterol depletion-mediated antitumor effects by regulating tumorigenic signaling pathways, ferroptosis and the TME. This evidence concerns the gene PCSK9 and neoplasm.